IPO
Carlyle-backed healthtech firm Indegene to file for Rs.2,500-Cr IPO: report
Bengaluru-based Indegene Pvt Ltd, a technology-led healthcare solutions provider, is planning an IPO of INR 2,500 crore. Indigent's Private Equity investor Carlyle is expected to sell its stake in the offer for sale (OFS) portion of the issue. The company has appointed JP Morgan India and Kotak Mahindra Capital Co. to manage the share sale. Indegene is engaged in R&D and engineering in natural sciences. It has a presence in the US, the UK, Europe, China, Japan, and India. The company provides solutions such as product commercialization, enterprise marketing and customer experience, data and analytics, medical transformation, and learning and development solutions. It mainly caters to biotech companies and medical device manufacturers.
From the Venture Intelligence PE-VC Deal Database: In Jan 21, Indegene had attracted USD 200 M from Carlyle and Brighton Park Capital. (Subscribers to the database can login to view the valuation, deal structuring and other transaction details.)
Want to receive such news items in your inbox? Click Here to sign up for a trial.
